|
|
||||||||
Unité de Recherche en Arthrose, Centre Hospitalier de lUniversité de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada
There is increasing evidence suggesting that chondrocyte death may contribute to the progression of osteoarthritis (OA). This study focused on the characterization of signaling cascade during NO-induced cell death in human OA chondrocytes. The NO generator, sodium nitroprusside (SNP), promoted chondrocyte death in association with DNA fragmentation, caspase-3 activation, and down-regulation of Bcl-2. Both caspase-3 inhibitor Z-Asp(OCH3)-Glu(OCH3)-Val-Asp(OCH3)-CH2F and caspase-9 inhibitor Z-Leu-Glu(OCH3)-His-Asp(OCH3)-CH2F prevented the chondrocyte death. Blocking the mitogen-activated protein kinase pathway by the mitogen-activated protein kinase kinase 1/2 inhibitor PD98059 or p38 kinase inhibitor SB202190 also inhibited the SNP-mediated cell death, suggesting possible requirements of both extracellular signal-related protein kinase 1/2 and p38 kinase for the NO-induced cell death. Furthermore, the selective inhibition of cyclooxygenase (COX)-2 by NS-398 or the inhibition of COX-1/COX-2 by indomethacin blocked the SNP-induced cell death. The chondrocyte death induced by SNP was associated with an overexpression of COX-2 protein (as determined by Western blotting) and an increase in PGE2 release. PD98059 and SB202190, but neither Z-DEVD FMK nor Z-LEHD FMK completely inhibited the SNP-mediated PGE2 production. Analysis of interactions between PGE2 and the cell death showed that PGE2 enhanced the SNP-mediated cell death, whereas PGE2 alone did not induce the chondrocyte death. These data indicate that NO-induced chondrocyte death signaling includes PGE2 production via COX-2 induction and suggest that both extracellular signal-related protein kinase 1/2 and p38 kinase pathways are upstream signaling of the PGE2 production. The results also demonstrate that exogenous PGE2 may sensitize human OA chondrocytes to the cell death induced by NO.
This article has been cited by other articles:
![]() |
M. I. Guillen, J. Megias, V. Clerigues, F. Gomar, and M. J. Alcaraz The CO-releasing molecule CORM-2 is a novel regulator of the inflammatory process in osteoarthritic chondrocytes Rheumatology, September 1, 2008; 47(9): 1323 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
J Monfort, J-P Pelletier, N Garcia-Giralt, and J Martel-Pelletier Biochemical basis of the effect of chondroitin sulphate on osteoarthritis articular tissues Ann Rheum Dis, June 1, 2008; 67(6): 735 - 740. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. R. Healy, F. Zhu, J. D. Stull, and K. Konstantopoulos Elucidation of the signaling network of COX-2 induction in sheared chondrocytes: COX-2 is induced via a Rac/MEKK1/MKK7/JNK2/c-Jun-C/EBP{beta}-dependent pathway Am J Physiol Cell Physiol, May 1, 2008; 294(5): C1146 - C1157. [Abstract] [Full Text] [PDF] |
||||
![]() |
C Boileau, F Poirier, J-P Pelletier, M Guevremont, N Duval, J Martel-Pelletier, and P Reboul Intracellular localisation of galectin-3 has a protective role in chondrocyte survival Ann Rheum Dis, February 1, 2008; 67(2): 175 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Surendran, S. H. Kim, B. K. Jee, S. H. Ahn, P. Gopinathan, and C. W. Han Anti-apoptotic Bcl-2 gene transfection of human articular chondrocytes protects against nitric oxide-induced apoptosis J Bone Joint Surg Br, December 1, 2006; 88-B(12): 1660 - 1665. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Rodriguez, P. De la Cerda, E. Collyer, V. Decap, C. P. Vio, and V. Velarde Cyclooxygenase-2 induction by bradykinin in aortic vascular smooth muscle cells Am J Physiol Heart Circ Physiol, January 1, 2006; 290(1): H30 - H36. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Mollace, C. Muscoli, E. Masini, S. Cuzzocrea, and D. Salvemini Modulation of Prostaglandin Biosynthesis by Nitric Oxide and Nitric Oxide Donors Pharmacol. Rev., June 1, 2005; 57(2): 217 - 252. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Sheu, F. M. Ho, R. S. Yang, K. F. Chao, W. W. Lin, S. Y. Lin-Shiau, and S.-H. Liu High Glucose Induces Human Endothelial Cell Apoptosis Through a Phosphoinositide 3-Kinase-Regulated Cyclooxygenase-2 Pathway Arterioscler. Thromb. Vasc. Biol., March 1, 2005; 25(3): 539 - 545. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Du, V. P. Sarthy, and T. S. Kern Interaction between NO and COX pathways in retinal cells exposed to elevated glucose and retina of diabetic rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2004; 287(4): R735 - R741. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Karatay, A. Kiziltunc, K. Yildirim, R. C. Karanfil, and K. Senel Effects of Different Hyaluronic Acid Products on Synovial Fluid Levels of Intercellular Adhesion Molecule-1 and Vascular Cell Adhesion Molecule-1 in Knee Osteoarthritis Ann. Clin. Lab. Sci., July 1, 2004; 34(3): 330 - 335. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. de Pascual-Teresa, K. L. Johnston, M. S. DuPont, K. A. O'Leary, P. W. Needs, L. M. Morgan, M. N. Clifford, Y. Bao, and G. Williamson Quercetin Metabolites Downregulate Cyclooxygenase-2 Transcription in Human Lymphocytes Ex Vivo but Not In Vivo J. Nutr., March 1, 2004; 134(3): 552 - 557. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Haider, I. Lee, J. Grabarek, Z. Darzynkiewicz, and N. R. Ferreri Dual Functionality of Cyclooxygenase-2 as a Regulator of Tumor Necrosis Factor-Mediated G1 Shortening and Nitric Oxide-Mediated Inhibition of Vascular Smooth Muscle Cell Proliferation Circulation, August 26, 2003; 108(8): 1015 - 1021. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P. Abulencia, R. Gaspard, Z. R. Healy, W. A. Gaarde, J. Quackenbush, and K. Konstantopoulos Shear-induced Cyclooxygenase-2 via a JNK2/c-Jun-dependent Pathway Regulates Prostaglandin Receptor Expression in Chondrocytic Cells J. Biol. Chem., August 1, 2003; 278(31): 28388 - 28394. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Smith and W. Baird Meloxicam and selective COX-2 inhibitors in the management of pain in the palliative care population American Journal of Hospice and Palliative Medicine, July 1, 2003; 20(4): 297 - 306. [Abstract] [PDF] |
||||
![]() |
J Martel-Pelletier, D Lajeunesse, P Reboul, and J-P Pelletier Therapeutic role of dual inhibitors of 5-LOX and COX, selective and non-selective non-steroidal anti-inflammatory drugs Ann Rheum Dis, June 1, 2003; 62(6): 501 - 509. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-B. Yoon, S.-J. Kim, S.-G. Hwang, S. Chang, S.-S. Kang, and J.-S. Chun Non-steroidal Anti-inflammatory Drugs Inhibit Nitric Oxide-induced Apoptosis and Dedifferentiation of Articular Chondrocytes Independent of Cyclooxygenase Activity J. Biol. Chem., April 18, 2003; 278(17): 15319 - 15325. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, J.-W. Ju, C.-D. Oh, Y.-M. Yoon, W. K. Song, J.-H. Kim, Y. J. Yoo, O.-S. Bang, S.-S. Kang, and J.-S. Chun ERK-1/2 and p38 Kinase Oppositely Regulate Nitric Oxide-induced Apoptosis of Chondrocytes in Association with p53, Caspase-3, and Differentiation Status J. Biol. Chem., January 4, 2002; 277(2): 1332 - 1339. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |